{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:28:31Z","timestamp":1759541311773},"reference-count":29,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2019,5,3]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Tissue fibrosis increases in the structure of the atrial tissue of atrial fibrillation patients. Prolidase enzyme regulates collagen synthesis. There may be an association between electrocardiography (ECG) findings and prolidase activity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>This study investigated the association between atrial conduction time and prolidase activity, a collagen synthesis enzyme, and P-wave dispersion (PWD) in patients with Paroxysmal Atrial Fibrillation (PAF).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Exclusion criteria included the age of &lt;18 years, heart failure, diabetes, hypertension, hyperlipidemia, malignancy, cerebrovascular disease, chronic respiratory distress, osteoporosis, rheumatoid arthritis, renal disease, cirrhosis, and other types of arrhythmia. Patients diagnosed with PAF within 48 hours were considered to have a definite diagnosis. PWD was calculated using a 12-lead ECG, and inter- and intraatrial electromechanical delay (EMD) was assessed using tissue Doppler imaging and conventional echocardiography. Serum prolidase levels were measured in both groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>A total of 43 patients with PAF (20 female, 23 male; mean age, 46.8 \u00b1 5.7 years) and 42 healthy volunteers (21 female, 21 male; mean age, 43.9 \u00b1 5.1 years) were included in the study.<\/jats:p><\/jats:sec><jats:sec><jats:title>:<\/jats:title><jats:p>Inter- and intraatrial EMD, PWD, minimum P-wave (Pmin), and maximum P-wave (Pmax) measurements were significantly higher (39.7 \u00b1 2.7, 35.7 \u00b1 2.3, p &lt; 0.001; 13.2 \u00b1 2.6, 8.5 \u00b1 1.9, p &lt; 0.001; 47.1 \u00b1 11, 24.1 \u00b1 7.1, p &lt; 0.001; 69.8 \u00b1 8.8, 66.7 \u00b1 10.2, p &lt; 0.130; 114.8 \u00b1 13, 93.6 \u00b1 8.6, p &lt; 0.001, respectively) and serum prolidase levels were significantly lower in patients with PAF compared to healthy controls (3.96 \u00b1 1.2, 8.5 \u00b1 3.56, p &lt; 0.001). In patients with PAF, correlation analysis showed a negative correlation between prolidase levels and intra- and interatrial EMD, PWD, and Pmax (r = -0.41, p &lt; 0.05; r = -0.54, p &lt; 0.05; r = -0.62, p &lt; 0.05; r = -0.49, p &lt; 0.05, respectively). Interatrial EMD showed a significant positive correlation with intraatrial EMD, Pmax, and PWD in patients with PAF (r = 0.90, p &lt; 0.05; r = 0.574, p &lt; 0.05; r = 0.43, p &lt; 0.05, respectively). Additionally, the level of high-sensitivity C-reactive protein (hs-CRP) was significantly higher in patients with PAF (6.6 \u00b1 8, 1.8 \u00b1 1.6, p &lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The decreased plasma prolidase activity in patients with PAF may explain the irregularity of the collagen metabolism of different extracellular components and may indicate the onset of atrial remodeling. Changes in PWD, interatrial EMD, and serum prolidase level may predict PAF before diagnosis.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1386207322666190306143317","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T11:13:28Z","timestamp":1551957208000},"page":"69-75","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Relationship Between Prolidase Activity and Atrial Electromechanical Changes in Patients with Paroxysmal Atrial Fibrillation"],"prefix":"10.2174","volume":"22","author":[{"given":"Mustafa Begenc","family":"Tascanov","sequence":"first","affiliation":[{"name":"Department of Cardiology, Harran University Faculty of Medicine, Sanliurfa, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ihj.2017.07.004","volume":"69","author":"Reddy V.","year":"2017","unstructured":"Reddy V, Taha W, Kundumadam S, Khan M. Indian Heart J, Atrial fibrillation and hyperthyroidism: A literature review.,, 2017, 69,, 545-550,","journal-title":"Indian Heart J"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/bph.13438","volume":"173","author":"Liu G.Z.","year":"2016","unstructured":"Liu GZ, Hou TT, Yuan Y, Hang PZ, Zhao JJ, Sun L, Zhao GQ, Zhao J, Dong JM, Wang XB. Br J Pharmacol, Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR\u2010\u03b1\/sirtuin 1\/PGC\u20101\u03b1 pathway.,, 2016, 173,, 1095-1109,","journal-title":"Br J Pharmacol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.STR.28.6.1101","volume":"28","author":"Feinberg W.M.","year":"1997","unstructured":"Feinberg WM, Cornell ES, Nightingale SD, Pearce LA, Tracy RP, Hart RG, Bovill EG. Stroke, Relationship between prothrombin activation fragment F1. 2 and international normalized ratio in patients with atrial fibrillation.,, 1997, 28,, 1101-1106,","journal-title":"Stroke"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"Chugh S.S.","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH, Zheng ZJ. Circulation, Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study.,, 2014, 129,, 837-847,","journal-title":"Circulation"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/1573403X10666140902143020","volume":"11","author":"Sankaranarayanan R.G.","year":"2015","unstructured":"Sankaranarayanan RG, Kirkwood R, Visweswariah DJ. Curr Cardiol Rev, How does chronic atrial fibrillation \u0131nfluence mortality in the modern treatment era?,, 2015, 11,, 190-198,","journal-title":"Curr Cardiol Rev"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrcardio.2016.118","volume":"13","author":"Nattel S.","year":"2016","unstructured":"Nattel S, Dobrev D. Nat Rev Cardiol, Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.,, 2016, 13,, 575-,","journal-title":"Nat Rev Cardiol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/eurjhf\/hfs163","volume":"14","author":"Frommeyer G.","year":"2012","unstructured":"Frommeyer G, Schmidt M, Clau\u00df C, Kaese S, Stypmann J, Pott C, Eckardt L, Milberg P. Eur J Heart Fail, Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure.,, 2012, 14,, 1322-1331,","journal-title":"Eur J Heart Fail"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.hjc.2017.01.027","volume":"58","author":"Zegkos T.","year":"2017","unstructured":"Zegkos T, Efthimiadis GK, Parcharidou DG, Gossios TD, Giannakoulas G, Ntelios D, Ziakas A, Paraskevaidis S, Karvounis HI. Hellenic J Cardiol, Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality.,, 2017, 58,, 331-339,","journal-title":"Hellenic J Cardiol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"Kirchhof P.","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J. Eur Heart J, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.,, 2016, 37,, 2893-2962,","journal-title":"Eur Heart J"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1097-4644(19971101)67:2<166::AID-JCB2>3.0.CO;2-V","volume":"67","author":"Palka J.A.","year":"1997","unstructured":"Palka JA, Phang JM. J Cell Biochem, Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors.,, 1997, 67,, 166-175,","journal-title":"J Cell Biochem"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0021-9258(18)74600-0","volume":"117","author":"Bergmann M.","year":"1937","unstructured":"Bergmann M, Fruton JS. J Biol Chem, On proteolytic enzymes, XII. Regarding the specificity of aminopeptidase and carboxypeptidase. A new type of enzyme in the intestinal tract.,, 1937, 117,, 189-202,","journal-title":"J Biol Chem"},{"key":"ref=12","first-page":"13","volume":"79","author":"Zanaboni G.","year":"1994","unstructured":"Zanaboni G, Dyne KM, Rossi A, Monafo V, Getta G. Haematologica, Prolidase deficiency: Biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients.,, 1994, 79,, 13-18,","journal-title":"Haematologica"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinchem\/30.2.211","volume":"30","author":"Myara I.","year":"1984","unstructured":"Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A. Clin Chem, Plasma prolidase activity: A possible index of collagen catabolism in chronic liver disease.,, 1984, 30,, 211-215,","journal-title":"Clin Chem"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0009-9120(02)00305-3","volume":"35","author":"Erba\u011fc\u0131 A.B.","year":"2002","unstructured":"Erba\u011fc\u0131 AB, Araz M, Erba\u011fc\u0131 A, Tarak\u00e7\u0131o\u011flu M, Nam\u0131duru ES. Clin Biochem, Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus.,, 2002, 35,, 263-268,","journal-title":"Clin Biochem"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00296-006-0247-8","volume":"27","author":"Altindag O.","year":"2007","unstructured":"Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Rheumatol Int, Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis.,, 2007, 27,, 339-344,","journal-title":"Rheumatol Int"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000183046","volume":"35","author":"Gejyo F.","year":"1983","unstructured":"Gejyo F, Kishore B, Arakawa M. Nephron, Prolidase and prolinase activities in the erythrocytes of patients with chronic uremia.,, 1983, 35,, 58-61,","journal-title":"Nephron"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.clinbiochem.2007.05.015","volume":"40","author":"Demirbag R.","year":"2007","unstructured":"Demirbag R, Y\u0131ld\u0131z A, Gur M, Yilmaz R, El\u00e7i K, Aksoy N. Clin Biochem, Serum prolidase activity in patients with hypertension and its relation with left ventricular hypertrophy.,, 2007, 40,, 1020-1025,","journal-title":"Clin Biochem"},{"key":"ref=18","first-page":"110","volume":"19","author":"Akt\u00fcrk E.","year":"2018","unstructured":"Akt\u00fcrk E, A\u015fk\u0131n L, Nacar H, Ta\u015folar MH, T\u00fcrkmen S, \u00c7etin M, Bozkurt M. Anatol J Cardiol, Association of serum prolidase activity in patients with isolated coronary artery ectasia.,, 2018, 19,, 110-,","journal-title":"Anatol J Cardiol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1357-4310(97)01193-3","volume":"4","author":"Bishop J.E.","year":"1998","unstructured":"Bishop JE. Mol Med Today, Regulation of cardiovascular collagen deposition by mechanical forces.,, 1998, 4,, 69-75,","journal-title":"Mol Med Today"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/eurheartj\/ehi645","volume":"27","author":"Boos C.J.","year":"2005","unstructured":"Boos CJ, Anderson RA, Lip GY. Eur Heart J, Is atrial fibrillation an inflammatory disorder.,, 2005, 27,, 136-149,","journal-title":"Eur Heart J"},{"key":"ref=21","first-page":"468","volume":"16","author":"Selcuk M.T.","year":"2007","unstructured":"Selcuk MT, Selcuk H, Maden O, Temizhan A, Aksu T, Do\u011fan M, Sasmaz A. J Heart Valve Dis, Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis.,, 2007, 16,, 468-474,","journal-title":"J Heart Valve Dis"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/hrt.2003.015347","volume":"90","author":"Boldt A.","year":"2004","unstructured":"Boldt A, Wetzel U, Lauschke J, Weigi J, Gummert J, Hindricks G, Kottkamp H, Dhein S. Heart, Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease.,, 2004, 90,, 400-405,","journal-title":"Heart"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2007.09.026","volume":"51","author":"Casaclang-Verzosa G.","year":"2008","unstructured":"Casaclang-Verzosa G, Gersh BJ, Tsang TS. J Am Coll Cardiol, Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.,, 2008, 51,, 1-11,","journal-title":"J Am Coll Cardiol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1067\/mje.2002.120202","volume":"15","author":"Qui\u00f1ones M.A.","year":"2002","unstructured":"Qui\u00f1ones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. J Am Soc Echocardiogr, Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography.,, 2002, 15,, 167-184,","journal-title":"J Am Soc Echocardiogr"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.echo.2005.01.015","volume":"18","author":"\u00d6zer N.","year":"2005","unstructured":"\u00d6zer N, Yavuz B, Can I, Atalar E, Aks\u00f6yek S, \u00d6v\u00fcn\u00e7 K, \u00d6zmen F, Kes S. J Am Soc Echocardiogr, Doppler tissue evaluation of intra-atrial and interatrial electromechanical delay and comparison with P-wave dispersion in patients with mitral stenosis.,, 2005, 18,, 945-948,","journal-title":"J Am Soc Echocardiogr"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","volume":"96","author":"Frustaci A.","year":"1997","unstructured":"Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Circulation, Histological substrate of atrial biopsies in patients with lone atrial fibrillation.,, 1997, 96,, 1180-1184,","journal-title":"Circulation"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.phrs.2004.08.004","volume":"51","author":"Sura\u017cy\u0144ski A.","year":"2005","unstructured":"Sura\u017cy\u0144ski A, Sienkiewicz P, Wo\u0142czy\u0144ski S, Pa\u0142ka J. Pharmacol Res, Differential effects of echistatin and thrombin on collagen production and prolidase activity in human dermal fibroblasts and their possible implication in \u03b21-integrin-mediated signaling.,, 2005, 51,, 217-221,","journal-title":"Pharmacol Res"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.arcmed.2008.03.002","volume":"39","author":"Rabus M.","year":"2008","unstructured":"Rabus M, Demirbag R, Yildiz A, Tezcan O, Yilmaz R, Ocak AR, Alp M, Erel O, Aksoy N, Yakut C. Arch Med Res, Association of prolidase activity, oxidative parameters, and presence of atrial fibrillation in patients with mitral stenosis.,, 2008, 39,, 519-524,","journal-title":"Arch Med Res"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jcla.20388","volume":"24","author":"Sezen Y.","year":"2010","unstructured":"Sezen Y, Bas M, Alt\u0131parmak H, Yildiz A, Buyukhatipoglu H, Faruk Dag O, Kaya Z, Aksoy N. J Clin Lab Anal, Serum prolidase activity in idiopathic and ischemic cardiomyopathy patients.,, 2010, 24,, 213-218,","journal-title":"J Clin Lab Anal"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T04:04:19Z","timestamp":1663041859000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170483\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207322666190306143317","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-11-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}